Keqian Biology released its performance for the first half of the year, with a net profit attributable to the parent company of 220 million yuan, an increase of 44.09%
I'm PortAI, I can summarize articles.
Keqian Biology released its 2025 semi-annual report, with operating revenue of 487 million yuan, a year-on-year increase of 21.67%; net profit attributable to the parent company was 220 million yuan, a year-on-year increase of 44.09%. The net profit after deducting non-recurring gains and losses was 190 million yuan, a year-on-year increase of 43.12%. Basic earnings per share were 0.47 yuan, benefiting from improved market conditions and increased sales
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments